Mr. Savard-Tremblay, thank you for the 40 seconds.
Mr. Medhora, I'd like to continue this conversation with you.
I think part of the dilemma right now for the parts of the world that are underserved in respect of vaccines is that we're being told that other places aren't really going to be able to manufacture anyway, so there's no point in giving them access to the intellectual property. It seems to come back to saying that industry has this well in hand. Industry doesn't want to give us any information about what they're doing, so we're just going to have to trust them.
If there were a justification for not granting access to IP and people not having more access to information about what is actually happening, like the prices that current producers are charging so that people.... People should be able to expect the same level of openness and transparency here that they would expect from a well-functioning government, given that it's of such vital public interest. This isn't your normal market for various kinds of drugs; this is a global public health and economic emergency.
I am wondering, at the risk of asking you to repeat yourself a bit, if you could clarify. What are some of the concrete things that could be done not only to increase the world supply of vaccines, but also to give people a degree of comfort that things are really being managed in the public interest, as opposed to the private interest of certain well-established corporations?